Bezlotoxumab: A Novel Agent for the Prevention of RecurrentClostridium difficileInfection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bezlotoxumab: A Novel Agent for the Prevention of RecurrentClostridium difficileInfection

Published:2017-09-12 Issue:10 Volume:37 Page:1298-1308
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Kufel Wesley D.¹²^ORCID,Devanathan Aaron S.¹²,Marx Ashley H.¹²,Weber David J.³⁴,Daniels Lindsay M.¹²

Affiliation:

1. Department of Pharmacy; University of North Carolina Medical Center; Chapel Hill North Carolina

2. Department of Practice Advancement and Clinical Education; University of North Carolina Eshelman School of Pharmacy; Chapel Hill North Carolina

3. Gillings School of Global Public Health; University of North Carolina at Chapel Hill; Chapel Hill North Carolina

4. School of Medicine; University of North Carolina at Chapel Hill; Chapel Hill North Carolina

Publisher

Wiley

Subject

Pharmacology (medical)

Reference60 articles.

1. Epidemiology, diagnosis and treatment of Clostridium difficile infection;Bassetti;Expert Rev Anti Infect Ther,2012

2. Clostridium difficile-more difficult than ever;Kelly;N Engl J Med,2008

3. Clostridium difficile infection: new developments in epidemiology and pathogenesis;Rupnik;Nat Rev Microbiol,2009

4. Burden of Clostridium difficile infection in the United States;Lessa;N Engl J Med,2015

5. Burden of Clostridium difficile on the healthcare system;Dubberke;Clin Infect Dis,2012

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An escape from ESKAPE pathogens: A comprehensive review on current and emerging therapeutics against antibiotic resistance;International Journal of Biological Macromolecules;2024-11

2. Antibiotics in the clinical pipeline as of December 2022;The Journal of Antibiotics;2023-06-08

3. The Efficacy of Bezlotoxumab in the Prevention of Recurrent Clostridium difficile: A Systematic Review;Cureus;2022-08-13

4. Anti-bacterial monoclonal antibodies: next generation therapy against superbugs;Applied Microbiology and Biotechnology;2022-06

5. Pseudomonas aeruginosa Biofilm Dispersion by the Human Atrial Natriuretic Peptide;Advanced Science;2022-01-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3